Epiregulin confers EGFR-TKI resistance via EGFR/ErbB2 heterodimer in non-small cell lung cancer - Ma, Shiqi; Zhang, Lu; Ren, Yuan; Dai, Wei; Chen, Tingqing; Luo, Liping; Zeng, Juan; Mi, Kun; Lang, Jinyi; Cao, Bangrong (Oncogene, 2021)
Keywords: 13/1; 13/106; 13/2; 13/31; 14/19; 42/109; 42/41; 42/89; 631/67/1059/602; 631/67/1612/1350; 692/53/2423; 82/80; AKT protein; Apoptosis; Cancer; Cell Biology; Cell viability; Drug resistance; Drug therapy; Epidermal growth factor; Epidermal growth factor receptors; ErbB-2 protein; Gefitinib; Gene expression; Genetic aspects; Human Genetics; Immunofluorescence; Inhibitor drugs; Internal Medicine; Kinases; Ligands; Lung cancer; Lung cancer, Non-small cell; Macrophages; Medicine; Medicine & Public Health; Mutation; Non-small cell lung carcinoma; Oncology; Oncology, Experimental; Patients; Phosphorylation; Protein-tyrosine kinase receptors; Proto-oncogenes; Small cell lung carcinoma; Tumor microenvironment; China